Aktie FINDIT INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Findit Inc Other OTC

Aktien

US04300W1080

Schlusskurs Other OTC
Andere Börsenplätze
- USD - Intraday Chart für Findit Inc
15.07. BioRegenx, Inc. gibt den Rücktritt von Jody M. Walker als Direktorin bekannt CI
08.03. BioRegenx, Inc. hat die Übernahme von Findit, Inc. (OTCPK:FDIT) von WooEB, Inc., Hva Family Trust und anderen in einer Reverse-Merger-Transaktion abgeschlossen. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BioRegenx, Inc. Announces the Resignation of Jody M. Walker as Director
BioRegenx : Non Reliance on Previously Issued Financial Report Form 8 K
FINDIT : Management Change/Compensation - Form 8-K
BioRegenx, Inc. completed the acquisition of Findit, Inc. from WooEB, Inc., Hva Family Trust and others in a reverse merger transaction.
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Findit, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
FINDIT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Findit, Inc. Auditor Raises 'Going Concern' Doubt
FINDIT, INC. : Entry into a Material Definitive Agreement (form 8-K)
BioRegenx, Inc. entered into a Definitive Agreement to acquire Findit, Inc. in a reverse merger transaction.
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Findit : Announces Investor Update
Findit : Featured Member BioRegenx Announces Investor Update
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14PEX Aktie
  4. Aktie
  5. Nachrichten Findit Inc
  6. Andere Sprachen